baber/WOPTO huggingface dataset:
Patent FI-883814-A0 (FI)
Inventor: YUMOTO HIDEAKI
IPC: F16T1/48
Filed: 1988-08-17
Abstract: The operation sensor of a steam trap is used for judging the operating condition of a steam trap used in various installations using a steam and consists of an oscillation detection portion (1) and an operation processing portion (50) for operation processing the signals detected by the oscillation detection portion and outputting the results. The detection portion (1) includes a detection needle (2) brought into contact with an object of detection at a predetermined pressure urged by a flexible member and detecting mechanical oscillation of the detection object resulting from the steam flow and condensation flow in the object, an oscillation plate (21) for generating ultrasonic oscillation by the mechanical oscillation detected by the detection needle (2), an oscillation sensor (16) disposed so as to oppose the oscillation plate (21) and converting the ultrasonic oscillation to an electrical signal and a circuit substrate (20) including an amplification circuit for suitably amplifying the output from the oscillation sensor (16) and transmitting it to the outside. The operation processing portion (50) includes memory (M) for storing data corresponding to steam traps of various types inclusive of the detection object, a central processing unit (CPU) for performing operation by comparing the output of the detection portion transmitted from the detection portion (1) with predetermined data obtained selectively from the stored data of memory (M) and output portions (D; S) for displaying the result of operation by the central processing unit (CPU) and/or generating an audible output with an audio frequency. The operation sensor includes a temperature sensor (10) added to the tip of the detection needle (2) of the detection portion and can detect the temperature and/or steam pressure of the detection object. Accordingly, the operating condition of the steam trap can be judged more accurately.
Patent FI-902351-A0 (FI)
Inventor: CALDERAZZO FAUSTO
IPC: C08F10/00
Filed: 1990-05-10
Abstract: Vanadium-arenes [V(arene)2] (arene = benzene or mono-, di-, or poly-alkyl-substituted benzene) are obtained, with a high yield, by means of the reduction of a vanadium-arene iodide with zinc, manganese or iron in metal form, or with cobalt di-(cyclopentadienyl). Vanadium-arenes are useful in the preparation of catalyst components active in ethylene polymerization, or in the copolymerization of ethylene in an alpha-olefin.
Patent FI-916111-A0 (FI)
Inventor: SEILER RONALD R
IPC: B29D30/56
Filed: 1991-12-23
Abstract: The invention relates to a pre-vulcanized replacement tread strip which is contoured to provide improved consistency in application, appearance and road endurance. The tread comprising a sole having a nominal arc in a cross-sectional plain of a pre-determined radius, respective tread shoulders, an upper tread portion disposed between said shoulders and overlying said sole, said upper tread portion having associated therewith a nominal arc extending between said tread shoulders and respective skirts, each skirt including a planar interior wall, an interior interconnection portion, an exterior side wall and an end portion, connecting said interior and exterior walls. There are given certains relations between radii and arc length which are decisive for a favourable retreading of a worn tire. <IMAGE>
Patent FI-923682-A0 (FI)
Inventor: SUOMI ARTO
IPC: H04W28/06
Filed: 1992-08-17
Abstract: PCT No. PCT/FI93/00322 Sec. 371 Date Apr. 15, 1994 Sec. 102(e) Date Apr. 15, 1994 PCT Filed Aug. 16, 1993 PCT Pub. No. WO94/05104 PCT Pub. Date Mar. 3, 1994An arrangement for enhancing data transmission in a digital cellular radio network, including a radio data terminal (A), a network terminating unit (IWF) connected to a mobile exchange (MSC) and including a data modem (MOD1), and a remote data modem (MOD2). The radio data terminal (A) and the remote data modem (MOD2) include features for providing data compression and decompression. The digital transmission connection between the radio data terminal (A) and the data modem (MOD1) is a non-transparent asynchronous data connection of a cellular radio system, over which compressed data is transmitted using the error correction of the cellular system. The error correction protocol of the remote modem is used for the transmission of compressed data over the modem connection between the data modem (MOD1) and the remote data modem (MOD2). At the beginning of a data session the data modem transmits compression parameters to the radio data terminal; these parameters are determined on the basis of a handshaking procedure between the data modem and the remote data modem.
Patent FI-945182-A0 (FI)
Inventor: MELTZER FRANK PETER
IPC: D21D1/30
Filed: 1994-11-03
Abstract: Roller mill and milling tool for milling suspended fibrous material. For particularly economical milling of suspended fibrous materials, roller mills and milling tools are utilized in which the radial extent of the working surfaces deviate from the state of the art in that the raised areas, acting in the manner of knives, form working surfaces which extend radially outwardly to a lesser extent than the base surfaces of the milling tools or the corresponding milling tool carriers, whereby it is feasible to utilize the shorter raised areas on the stator side, the rotor side, or on both sides, thereby, via these measures, achieving a particularly economical and uniform comminution.
Patent FI-956122-A0 (FI)
Inventor: LINDALL KARL B
IPC: H03B1/04
Filed: 1995-12-19
Abstract: In an electronic apparatus including a reference oscillator and an interfering part that generates an interference signal having a spectral component within a receiver bandwidth, the reference oscillator supplying a reference oscillating signal to the interfering part from which reference oscillating signal the interference signal is derived, amplitude of the interference signal within the receiver bandwidth is reduced by angle modulating the reference oscillating signal with a sinusoidal signal to generate an angle modulated interference signal having a reduced carrier amplitude and modulation sidebands that are outside of the receiver bandwidth. The angle modulated interference signal preferably has a modulation index,  beta , that is close to a solution of the equation J0( beta )=0, where J0 is a Bessel function of the first kind. Angle modulation may alternatively be accomplished by applying direct frequency modulation to the reference oscillator with the sinusoidal signal to generate a modulated reference signal and then applying the modulated reference signal to the interfering part, or by phase modulating the reference oscillating signal with the sinusoidal signal prior to supplying it to the interfering part. Where the interference signal has an interfering spectral component within a measurement bandwidth, the amplitude of the interfering spectral component is reduced by using a deterministic, non-noise modulating signal, such as a sawtooth waveform modulating signal, to angle modulate a clock signal from which the interference signal is derived.
Patent FI-974021-A0 (FI)
Inventor: RANTONEN MARKKU
IPC: F23J1/06
Filed: 1997-10-22
Abstract: Grate (1) comprises essentially concentrically set stationary and rotating unified grate rings (6a-d, 7a-c), which alternate from the centre outwards to the peripheral ring. Each grate ring is lower than the next ring further in and has a larger diameter than it, when the fuel fed from beneath to the centre of the grate flows over the grate rings while it burns to the peripheral ring, in which the ash drops through openings (30) arranged in it to an ashbox (5). The peripheral ring has stationary and circumferentially oriented moving units (15, 16), which are arranged in one extreme position to cover the entire peripheral ring and in the opposite extreme position to interlap in pairs on top of each other and form the aforesaid openings (30) between the interlapped pairs.
Patent FI-980479-A0 (FI)
Inventor: JOKELA PETRI AULIS
IPC: H04W4/02
Filed: 1998-03-03
Abstract: The present invention relates to method, arrangement and apparatus for providing a mobile user with information retrievable from a database. The method comprises the steps of establishing a communications connection between a mobile station and a base station or base stations of a mobile communications network. The location of the mobile station is then determined on the basis of the base station or base stations, and this identified location information is processed in the mobile communications network so as to enable a retrieval of area related information relating to the determined location from the database. Said retrieved area related information is then transmitted to the mobile station.
Patent BE-1005196-A0 (BE)
Title: Compositions pharmaceutiques aqueuses de cromoglycate sodique.
IPC: A61K9/00
Filed: 1993-03-08
Abstract: Composition pharmaceutiques comprenant une solution aqueuse sensiblement limpide, qui a une viscosité de moins de 10 mPa.s et qui contient 3,5 à 5% p/v de 1,3-bis (2-carboxychromon-5-yloxy) propane-2-ol, ou d'un sel pharmaceutiquement acceptable de celui-ci, comme constituant actif et du glycérol, la concentration en ions des métaux des groupes IIA, IB, IIB et IVB du tableau périodique ou des métaux de transition étant inférieure à 20 ppm.La composition convient spécialement pour le traitement des affections de l'oeil.
Patent IL-79189-A0 (IL)
Title: Pyridonecarboxylic acid derivatives
IPC: A61K31/47
Filed: 1986-06-23
Abstract: This invention provides novel pyridonecarboxyic acid derivatives having a quite high antimicrobial activity. The derivatives have the following formula:wherein R<sup>1</sup>, R<sup>2</sup> and R<sup>3</sup> represent each a hydrogen or C<sub>1</sub>-C<sub>8</sub> alkyl group; R<sup>4</sup> represents an ethyl, 2-fluoroethyl, vinyl, isopropyl, isopropenyl or cyclopropyl group; and X represents CH, C-F, C-Cl or N characterized in that R<sup>2</sup> and R<sup>3</sup> are not hydrogen at the same time.
Patent IL-92771-A0 (IL)
Title: Method for achieving a flat screen with an active memory and ram,using mim components
IPC: G09F9/30
Filed: 1989-12-18
Abstract: The process according to the invention comprises the following operations: - a stack is formed of a first material which is an oxidising conductor and of a second material which is an oxidisable conductor and preferably a semiconductor, - this stack is brought to a temperature able to engender a redox reaction between the two materials, this forming an insulating insert layer, - the whole is brought back to ambient temperature. 
<??>Application in electronics, in the production of active matrix liquid crystal display screens, or of dynamic RAM memory. 
<IMAGE>
Patent IL-97006-A0 (IL)
Title: Transdermal therapeutic system comprising tulobuterol as active substance
IPC: A61M37/00
Filed: 1991-01-23
Abstract: The invention relates to a transdermal therapeutic system containing tulobuterol or one of its pharmaceutically compatible salts as active ingredient, comprising a backing layer which is essentially impermeable to active ingredient, and at least one matrix layer which contains the active ingredient and contains at least one styrene/1,3-diene/styrene block copolymer, and to a process for the production thereof.
Patent FI-20106387-A0 (FI)
Inventor: LUKKA TUOMAS
Filed: 2010-12-30
Abstract: According to one aspect of the invention, there is provided a method comprising: obtaining at least one image comprising at least one object; analysing the at least one image to determine at least one gripping location to grip an object; selecting a gripping location from the at least one gripping location based on a predetermined criterion; and issuing at least one instruction to a gripper to grip the object at the selected gripping location.
Patent IL-104049-A0 (IL)
Title: 7'-amino-naphthazarin antibiotic derivatives
IPC: C07D493/20
Filed: 1992-12-10
Abstract: PCT No. PCT/EP92/02764 Sec. 371 Date May 26, 1994 Sec. 102(e) Date May 26, 1994 PCT Filed Nov. 30, 1992 PCT Pub. No. WO93/12115 PCT Pub. Date Jun. 24, 1993.The present invention concerns novel naphthazarin antibiotic derivatives having general formula I    <IMAGE>  (I)  and the pharmaceutically acceptable addition salts thereof.
Patent IL-106975-A0 (IL)
Title: Nutrition for persons infected with human immunodeficiency virus
IPC: A61P31/12
Filed: 1993-09-10
Abstract: An enteral nutritional product for persons infected with human immunodeficiency virus contains a soy protein hydrolysate having a molecular weight partition, as determined by size exclusion chromatography, wherein 30-60% of the particles have a molecular weight in the range of 1500-5000 Daltons. The nutritional product also contains a source of intact protein. The nutritional product has a ratio, by weight, of n-6 to n-3 fatty acids of about 1.3:1 to 2.5:1. Enteral nutritional support of a person infected with human immunodeficiency virus may be provided by including this enteral nutritional product in the infected person's diet. Apoptosis of CD4 cells in a person infected with human immunodeficiency virus may be impeded by feeding the infected person this enteral nutritional product.
Patent IL-108744-A0 (IL)
Title: Cylindrical cooling device for therapeutic treatment of hemorrhoids
IPC: A61F7/12
Filed: 1994-02-22
Abstract: A cooling cylindrical device for removal of pain and therapeutic treatment of hemorrhoids and anal fissures comprising a hollow insert, finger or bulb adapted in its contour for insertion into the anus with at least one inlet and/or outlet openings at its upper base, one or two tubes connected to said openings, and at least one container for cold liquid circulation starting from a container through an inlet tube into the cylindrical insert and wherein the liquid is driven back through the outlet opening and through the second tube to the container operated by a pump connected to the container or back to another container operated by gravity. <IMAGE>
Patent IL-112613-A0 (IL)
Title: Pyrrolidine derivatives
IPC: A61K38/00
Filed: 1995-02-12
Abstract: The present invention relates to pyrrolidine derivatives, and more particularly to the compound (S)-1-[(S)-2-(4-methoxybenzamido)-3-methylbutyryl]-N-[(S)-2-methyl-1-(trifluoroacetyl)propyl]pyrrolidine-2-carboxamide, shown by formula I, and solvates thereof. The present invention also provides pharmaceutical compositions, intermediates and methods of preparation of the compound. The compound of formula I is an inhibitor of human neutrophil elastase and is useful in the treatment of diseases in which the enzyme is implicated, such as, for example, emphysema and acute respiratory distress syndrome (ARDS).
Patent IL-116442-A0 (IL)
Title: Preparation of E-oxime ethers of phenylglyoxylic acids and novel omicron-phenoxymethylphenyl-glyoxylic methyl esters used therefor
IPC: C07C69/736
Filed: 1995-12-19
Abstract: Process for the preparation of E-oxime ethers of phenylglyoxylic acid esters of the general formula I 
<IMAGE>
 in which the variables have the following meanings: 
 
  the substituents X and Y are selected from a group comprising halogen, C1-C4-alkyl, C1-C4-alkoxy or trifluoromethyl; 
  m is an integer from 0 to 4; 
  n is an integer from 0 to 3,
 and in which 
 
  a) a phenol of the general formula II 
<IMAGE>
 is converted into the phenolate, 
  b) the latter is mixed with a lactone of the general formula III 
<IMAGE>
 
  c) the molten mixture is reacted, and 
  d) the resulting 2-phenoxymethylbenzoic acid of the general formula IV 
<IMAGE>
 is converted, via the acid chloride, into the benzoyl cyanide and this is converted into the corresponding alpha-keto acid, which is converted into the compound I. 
 
 Alternatively, the compound IV can be converted, via the ester, into the beta-keto sulphoxide, which is reacted to give the beta-keto ester, which is subsequently converted into the compound I.
Patent IL-133898-A0 (IL)
Title: Method and device for formatting a digital audio signal to be used for sound reproduction
IPC: H04R1/00
Filed: 1998-07-06
Abstract: The invention concerns a method which consists in using digital sampling of a live sound recording or of an original sound medium, which is copied then formatted into a multiple reproduction of the original sampling. In order to observe the original time base, the multiple reproduction of copies, leads to the multiple reproduction of the sampling speed of the new digital signal. The quantization parameter can be identical to the original, or be subjected to value scaling, or be in reciprocal value. An apparatus formatting digital audio signal acquires a reference sampling from a digital decoder, then multiplies its data by adjustable independent samplers managed by a common clock. A relay programs the regular and cyclical activities of the samplers, determining a new digital sound signal. Said signal can be smoothed for analog use by fragile transducers. This formatting process adapted for acoustic transducers, can be used for recording and as audio signal software for transferring sound data.
Patent IL-135226-A0 (IL)
Title: Method and apparatus for protection of recorded digital data
IPC: H04L9/08
Filed: 1998-09-22
Abstract: A method of protecting recorded digital data on a digital support medium 2 characterised in encrypting one or more elements of the volume descripter V associated with the support medium 2 by means of a first key Kf and diversifier Cf, storing an equivalent of the first key Kf and diversifier Cf on an integrated circuit embedded in a smart card 4 associated with the support medium 2. The encrypted volume descripter elements E1(V) are then stored on the support medium 2. When accessing the recording, the keys Kf, Cf stored in the integrated circuit are used to decrypt the encrypted elements of the volume descripter E1(V) and to supply the reader 5 with the decrypted elements V so as to permit the reading and/or writing of recorded data on the support medium. <IMAGE>
Patent IL-145378-A0 (IL)
Title: A diagnostic test
IPC: C12Q1/34
Filed: 2000-03-17
Abstract: There is provided a method for the detection of a disease comprising the following steps: 
(i) obtaining a biological sample from a human subject; 
(ii) applying the biological sample to a sialidase which has been immobilised on a solid support medium; and 
(iii) detecting a change in the immobilised sialidase substrate.  The substrate is preferably 5-bromo-4-chloro-3-indoyl ±-D-N-acetyl neuraminic acid or a salt thereof.
Patent IL-145674-A0 (IL)
Title: USE OF ERbB RECEPTOR LIGANDS IN TREATING DIABETES
IPC: C07K16/32
Filed: 2000-04-05
Abstract: The invention provides methods for treating pancreatic dysfunction, particularly diabetes, in mammals using ErbB receptor ligands, such as heregulin, betacellulin, and EGF. Methods of treating such conditions using anti-ErbB receptor agonist antibodies are further provided. The methods of the invention may be performed by direct administration of such therapeutically useful agents to mammals, or alternatively, by exposing certain pancreatic cell types to such agents in vitro and subsequently transplanting the treated cells to a mammal.
Patent IL-146127-A0 (IL)
Title: Conformationally restricted polymine analogs as disease therapies
IPC: A61K31/132
Filed: 2000-04-27
Abstract: Novel conformationally restricted polyamine analogs are provided, as well as compositions comprising these novel polyamine analogs. Methods of using the novel polyamine analogs in treatment of diseases such as cancer are also provided. Also provided is a method of delivering these analogs specifically to tumor cells by covalently attaching polyamine analogs to porphyrin compounds, along with novel polyamine-porphyrin covalent conjugates.
Patent IL-148361-A0 (IL)
Title: Benzylidene-thiazolidinedione derivatives and pharmaceutical compositions containing the same
IPC: A61P15/00
Filed: 2000-08-31
Abstract: The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.
Patent IL-152767-A0 (IL)
Title: Preparation of injectable suspensions having improved injectability
IPC: A61K47/38
Filed: 2001-04-19
Abstract: Injectable compositions having improved injectability. The injectable compositions include microparticles in an aqueous injection vehicle having a viscosity of at least 20 cp at 20 °C. The increased viscosity of the injection vehicle that constitutes the fluid phase of the suspension significantly reduces  in vivo  injectability failures. The injectable compositions can be made by mixing dry microparticles with an aqueous injection vehicle to form a suspension, and then mixing the suspension with a viscosity enhancing agent to increase viscosity of the fluid phase of the suspension to the desired level for improved injectability.
Patent IL-156639-A0 (IL)
Title: Phenethanolamine derivatives, methods for their preparation and pharmaceutical compositions containing them
IPC: A61P43/00
Filed: 2001-12-17
Abstract: The present invention discloses compounds of Formula I. The present invention also discloses beta-3 agonists of formula I and methods for treating beta-3 mediated diseases and condition using the compounds of formula I, in particular methods for treating diabetes or obesity.
Patent IL-159053-A0 (IL)
Title: Modulators of pharmacological agents
IPC: G01N33/566
Filed: 2002-05-28
Abstract: The biological activity of nucleic acid ligand is regulated (i.e. enhanced or inhibited) in vivo to produce a desired biological effect. This is accomplished through the administration of a pharmaceutical composition comprising a modulator that changes the binding of the nucleic acid ligand for its target or that degrades or otherwise cleaves, metabolizes or breaks down the nucleic acid ligand while the ligand is still exerting its effect. Modulators of the present invention can be administered in real time as needed based on various factors including the progress of the patient, as well as the physician's discretion in how to achieve optimal therapy. Thus, this invention provides for the first time a regulatable therapeutic regime in the course of nucleic acid ligand therapy.
Patent IL-183236-A0 (IL)
Title: Rasagiline orally disintegrating compositions
Filed: 2007-05-15
Abstract: This invention provides a solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline, and particles having a non-filamentous microstructure of at least two sugar alcohols. This invention also provides a solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline, a mixture of a disintegrant, a flow agent and particles having a non-filamentous microstructure of at least two sugar alcohols, a supplemental sugar alcohol, a supplemental flow agent, and a supplemental disintegrant. This invention further provides a method of treating a subject afflicted with Parkinson's disease comprising administering to the subject a therapeutically effective amount of the solid pharmaceutical composition, thereby treating the subject. Finally, this invention provides a process of making such solid pharmaceutical compositions.